Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

43.67
Delayed Data
As of Sep 28
 +0.35 / +0.81%
Today’s Change
36.71
Today|||52-Week Range
45.58
+9.78%
Year-to-Date
Ariel Funds Comments on GlaxoSmithKline plc
Sep 28 / GuruFocus News - Paid Partner Content
3 Stocks to Avoid in Healthcare
Sep 28 / MotleyFool.com - Paid Partner Content
John Rogers' Ariel Global Fund 2nd Quarter Commentary
Sep 28 / GuruFocus News - Paid Partner Content
New Research Reports for GE, McDonald's & GSK
Sep 27 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: General Electric, GlaxoSmithKline and McDonald
Sep 28 / Zacks.com - Paid Partner Content
The Internet of Medical Things: 6 Stocks in Focus
Sep 26 / Zacks.com - Paid Partner Content
GlaxoSmithKline Vaccines for Malaria, Zika Make It a Likely Winner
Sep 28 / TheStreet.com - Paid Partner Content
Glaxo/J&J File BLA for Rheumatoid Arthritis Drug in the U.S.
Sep 26 / Zacks.com - Paid Partner Content
Battle of the Pharmaceutical Bigwigs: GlaxoSmithKline vs. Pfizer
Sep 28 / TheStreet.com - Paid Partner Content
The skill employers really want from new recruits
Sep 23 / CNNMoney.com

Today’s Trading

Previous close43.32
Today’s open43.72
Day’s range43.30 - 43.78
Volume1,969,010
Average volume (3 months)3,134,692
Market cap$105.6B
Dividend yield5.05%
Data as of 4:02pm ET, 09/28/2016

Growth & Valuation

Earnings growth (last year)+181.82%
Earnings growth (this year)+13.78%
Earnings growth (next 5 years)+11.95%
Revenue growth (last year)-3.66%
P/E ratioNM
Price/Sales2.70
Price/Book13.91

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie-0.35-0.54%
SNYSanofi+0.52+1.36%
AGNAllergan-1.57-0.66%
BMYBristol-Myers Squibb-0.65-1.17%
Data as of 4:03pm ET, 09/28/2016

Financials

Next reporting dateOctober 26, 2016
EPS forecast (this quarter)$0.77
Annual revenue (last year)$36.5B
Annual profit (last year)$12.8B
Net profit margin35.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Andrew Philip Witty
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts

Search for Jobs